Controlling schistosomiasis with praziquantel: How much longer without a viable alternative?
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2049-9957
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Controlling schistosomiasis with praziquantel: How much longer without a viable alternative? ; volume:6 ; number:1 ; day:28 ; month:3 ; year:2017 ; pages:1-10 ; date:12.2017
Infectious diseases of poverty ; 6, Heft 1 (28.3.2017), 1-10, 12.2017
- Keyword
-
Infektion
Infektiologie
- Creator
-
Bergquist, Robert
- Contributor
- DOI
-
10.1186/s40249-017-0286-2
- URN
-
urn:nbn:de:1111-201704159738
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:38 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bergquist, Robert
- Utzinger, Jürg
- Keiser, Jennifer
- SpringerLink (Online service)
Other Objects (12)
Investigation on birth weight outcomes in schistosomiasis and praziquantel research: a correspondence
Praziquantel and Upper Gastrointestinal Bleeding in Hepatic Schistosomiasis: A Quasi-Experimental Study
A diagnostic challenge for schistosomiasis japonica in China: consequences on praziquantel-based morbidity control
Single oral fixed-dose praziquantel-miltefosine nanocombination for effective control of experimental schistosomiasis mansoni
Antimalarial artesunate–mefloquine versus praziquantel in African children with schistosomiasis: an open-label, randomized controlled trial
Schistosomiasis control in Senegal: results from community data analysis for optimizing preventive chemotherapy intervention with praziquantel
Biltricide/Praziquantel (Bayer)
Correction: Schistosomiasis control in Senegal: results from community data analysis for optimizing preventive chemotherapy intervention with praziquantel
Praziquantel treatment coverage among school age children against Schistosomiasis and associated factors in Ethiopia: a cross-sectional survey, 2019
Praziquantel coverage in schools and communities targeted for the elimination of urogenital schistosomiasis in Zanzibar: a cross-sectional survey
Why did the average duration of unemployment become so much longer?
Repeated doses of Praziquantel in Schistosomiasis Treatment (RePST) – single versus multiple praziquantel treatments in school-aged children in Côte d’Ivoire: a study protocol for an open-label, randomised controlled trial
Investigation on birth weight outcomes in schistosomiasis and praziquantel research: a correspondence
Praziquantel and Upper Gastrointestinal Bleeding in Hepatic Schistosomiasis: A Quasi-Experimental Study
A diagnostic challenge for schistosomiasis japonica in China: consequences on praziquantel-based morbidity control
Single oral fixed-dose praziquantel-miltefosine nanocombination for effective control of experimental schistosomiasis mansoni
Antimalarial artesunate–mefloquine versus praziquantel in African children with schistosomiasis: an open-label, randomized controlled trial
Schistosomiasis control in Senegal: results from community data analysis for optimizing preventive chemotherapy intervention with praziquantel
Biltricide/Praziquantel (Bayer)
Correction: Schistosomiasis control in Senegal: results from community data analysis for optimizing preventive chemotherapy intervention with praziquantel
Praziquantel treatment coverage among school age children against Schistosomiasis and associated factors in Ethiopia: a cross-sectional survey, 2019
Praziquantel coverage in schools and communities targeted for the elimination of urogenital schistosomiasis in Zanzibar: a cross-sectional survey
Why did the average duration of unemployment become so much longer?
Repeated doses of Praziquantel in Schistosomiasis Treatment (RePST) – single versus multiple praziquantel treatments in school-aged children in Côte d’Ivoire: a study protocol for an open-label, randomised controlled trial
Investigation on birth weight outcomes in schistosomiasis and praziquantel research: a correspondence
Praziquantel and Upper Gastrointestinal Bleeding in Hepatic Schistosomiasis: A Quasi-Experimental Study
A diagnostic challenge for schistosomiasis japonica in China: consequences on praziquantel-based morbidity control
Single oral fixed-dose praziquantel-miltefosine nanocombination for effective control of experimental schistosomiasis mansoni
Antimalarial artesunate–mefloquine versus praziquantel in African children with schistosomiasis: an open-label, randomized controlled trial
Schistosomiasis control in Senegal: results from community data analysis for optimizing preventive chemotherapy intervention with praziquantel
Biltricide/Praziquantel (Bayer)
Correction: Schistosomiasis control in Senegal: results from community data analysis for optimizing preventive chemotherapy intervention with praziquantel
Praziquantel treatment coverage among school age children against Schistosomiasis and associated factors in Ethiopia: a cross-sectional survey, 2019
Praziquantel coverage in schools and communities targeted for the elimination of urogenital schistosomiasis in Zanzibar: a cross-sectional survey
Why did the average duration of unemployment become so much longer?